Heartmate 3 Implantation in Cancer Survivors with Advanced Heart Failure

There are over 15 million Cancer Survivors (CSr) in the United States and this number is estimated to increase further with improvement in cancer therapeutics and an aging population. In previous studies, CSr undergoing Left Ventricular Assist Device (LVAD) implantation were found to have worse outcomes than patients without a history of cancer. The aim of this study was to ascertain the effect of a previous history of cancer on adverse events and survival in patients undergoing HeartMate 3(HM3) implantation.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: J. Raikhelkar, J. Fried, N. Sumzin, K. Clerkin, J. Griffin, J. Sanchez, D. Marshall, M. Yuzefpolskaya, P. Colombo, Y. Naka, H. Takayama, V. Topkara, G. Sayer, K. Takeda, N. Uriel Tags: (434) Source Type: research